Moran Kyle (CIK 1657765) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-11). Recent activity: Buy WVE (45,625 shares), Sell WVE (3,588 shares), Buy WVE (60,000 shares), Sell WVE (60,000 shares), Buy WVE (100,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-11 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Buy | 45,625 | $0 |
| 2026-02-11 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 3,588 | $48,259 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Buy | 60,000 | $169,800 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 60,000 | $792,000 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Buy | 100,000 | $314,000 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 50,000 | $750,000 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 50,000 | $660,000 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Buy | 50,000 | $237,500 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 50,000 | $900,000 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Buy | 36,000 | $294,120 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 36 | $729 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Buy | 50,000 | $524,000 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | Sell | 50,000 | $1.0M |
来源：SEC Form 4 申报文件 · 截至 2026-02-11